Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Authors including 'Liechti_M'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Vollenweider FX, Gamma A,... Psychological and cardiovascular effects and short-term sequelae of MD... Neuropsychopharmacol... 1998
Vollenweider FX, Gamma A,... Is a single dose of MDMA harmless? Neuropsychopharmacol... 1999
Gamma A, Buck A, Berthold... 3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic... Neuropsychopharmacol... 2000
Liechti ME, Baumann C, Ga... Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA... Neuropsychopharmacol... 2000
Liechti ME, Saur MR, Gamm... Psychological and Physiological Effects of MDMA ('Ecstasy') after Pret... Neuropsychopharmacol... 2000
Liechti ME, Vollenweider ... Acute psychological and physiological effects of MDMA ('Ecstasy') afte... Eur Neuropsychopharm... 2000
Liechti ME, Vollenweider ... The serotonin uptake inhibitor citalopram reduces acute cardiovascular... J Psychopharmacol 2000
Liechti ME, Gamma A, Voll... Gender Differences in the Subjective Effects of MDMA Psychopharmacology 2001
Liechti ME, Geyer MA, Hel... Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of St... Neuropsychopharmacol... 2001
Liechti ME, Vollenweider ... Which neuroreceptors mediate the subjective effects of MDMA in humans?... Hum Psychopharmacol ... 2001
Vollenweider FX, Liechti ... Acute psychological and neurophysiological effects of MDMA in humans J Psychoactive Drugs 2002
Gamma A, Jerome L, Liecht... Is ecstasy perceived to be safe? A critical survey Drug and Alcohol Dep... 2005
Vollenweider FX, Liechti ... MDMA affects both error-rate dependent and independent aspects of deci... J Psychopharmacol 2005
Liechti ME, Kunz I, Kupfe... Acute medical problems due to Ecstasy use. Case-series of emergency de... Swiss Med Wkly 2005
Derungs A, Schietzel S, M... Sympathomimetic toxicity in a case of analytically confirmed recreatio... Clinical Toxicology 2011
Simmler LD, Buser TA, Don... Pharmacological characterization of designer cathinones in vitro Br J Pharmacol 2013
Kirkpatrick MG, Baggott M... MDMA effects consistent across laboratories Psychopharmacology (... 2014
Rickli A, Kopf S, Hoener ... Pharmacological profile of novel psychoactive benzofurans Br J Pharmacol 2015
Rickli A, Luethi D, Reini... Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) deriv... Neuropharmacology 2015
Liakoni E, Dolder PC, Ren... Presentations due to acute toxicity of psychoactive substances in an u... BMC Pharmacol Toxico... 2016
Stoller A, Dolder PC, Bod... Mistaking 2C-P for 2C-B: What a Difference a Letter Makes J Anal Toxicol 2016
Liechti ME Modern Clinical Research on LSD Neuropsychopharmacol... 2017
Luethi D, Kolaczynska KE,... Pharmacological profile of mephedrone analogs and related new psychoac... Neuropharmacology 2017
Rickli A, Liakoni E, Hoen... Opioid-induced inhibition of the human 5-HT and noradrenaline transpor... Br J Pharmacol 2018
Liechti ME Modern Clinical Research on LSD Neuropsychopharmacol... 2018
Luethi D, Liechti ME Monoamine transporter and receptor interaction profiles in vitro predi... Int J Neuropsychopha... 2018
Rickli A, Kolaczynska K, ... Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-D... Neurotoxicology 2019
Ramaekers JG, Hutten N, M... A low dose of lysergic acid diethylamide decreases pain perception in ... J Psychopharmacol 2020